SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-099792
Filing Date
2020-08-28
Accepted
2020-08-28 08:05:17
Documents
13
Period of Report
2020-08-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2029766-1_8k.htm   iXBRL 8-K 36265
  Complete submission text file 0001104659-20-099792.txt   260026

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fbio-20200827.xsd EX-101.SCH 3782
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20200827_def.xml EX-101.DEF 27399
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20200827_lab.xml EX-101.LAB 37117
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20200827_pre.xml EX-101.PRE 26024
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2029766-1_8k_htm.xml XML 5449
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 201144901
SIC: 2834 Pharmaceutical Preparations